Abdullah Saud Alshetaili

Pharmacology, Toxicology and Pharmaceutical Science

1. Amorphous Solid Dispersion 22%
2. Anti-Inflammatory Drug 18%
3. Anticarcinogen 19%
4. Antihypertensive Agent 13%
5. Antioxidant 13%
6. Atopic Dermatitis 17%
7. Bioavailability 83%
8. Breast Cancer 41%
9. Carbamazepine 15%
10. Carbon Dioxide 28%
11. Chemokine 13%
12. Chitosan 32%
13. Cytokine 16%
14. Cytotoxicity 22%
15. Differential Scanning Calorimetry 32%
16. Dosage Form 14%
17. Drug Delivery System 56%
18. Drug Release 55%
19. Drug Solubility 30%
20. Eudragit 24%
21. Excipient 14%
22. Fenofibrate 20%
23. Ibrutinib 15%
24. Inflammation 17%
25. Intravaginal Administration 15%
26. Lipid 22%
27. Lung Cancer 21%
28. Luteolin 20%
29. Macrogol 13%
30. Malignant Neoplasm 21%
31. Mefenamic Acid 41%
32. Nanocarrier 18%
33. Nanogel 43%
34. Nanoparticle 100%
35. Non Small Cell Lung Cancer 15%
36. Pharmaceutics 13%
37. Pharmacodynamics 15%
38. Pharmacokinetic 47%
39. Poloxamer 28%
40. Polyethylene Glycol 15%
41. Polyglactin 26%
42. Povidone 33%
43. Rat 42%
44. Scanning Electron Microscopy 20%
45. Simvastatin 20%
46. Solid Lipid Nanoparticle 24%
47. Sunitinib 20%
48. Sustained Release 22%
49. Tablet 87%
50. Zeta Potential 37%